South African Labs Strive for Africa’s Biopharma Sovereignty

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 26 Oct, 18:55 UTC

Africa still imports 99% of its routine vaccines and 70–90% of its biopharmaceuticals. The Africa CDC warns this vulnerability could cost the continent up to $1.1 trillion in skills and jobs through 2050. The post South African Labs Strive for Africa’s Biopharma Sovereignty appeared first on GEN…

sciencesecurity

Sources

• T2South African Labs Strive for Africa’s Biopharma SovereigntyFierce Biotech / Fierce Healthcare / MedCity / GEN26 Oct, 18:55